The Valley Desk

NCT02559570 · Interventional trial

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Overall registry status Completed

Phase 2

Conditions Functional Constipation in Children Ages 6-17 Years

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov